AAAAAA

   
Results: 1-7 |
Results: 7
Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients
Authors: Venturini, M Michelotti, A Papaldo, P Del Mastro, L Bergaglio, M Lionetto, R Lunardi, G Sguotti, C Frevola, L Donati, S Rosso, R Cognetti, F
Citation: M. Venturini et al., Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients, ANN ONCOL, 12(8), 2001, pp. 1097-1106
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients
Authors: Del Mastro, L Venturini, M Viscoli, C Bergaglio, M Signorini, A Bighin, C Bertell, G Semino, C Pietra, G Bertoglio, S Sertoli, MR Lambiase, A Rosso, R Melioli, G
Citation: L. Del Mastro et al., Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients, ANN ONCOL, 12(4), 2001, pp. 505-508
Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients. (vol 12, pg 1097, 2001)
Authors: Venturini, M Michelotti, A Papaldo, P Del Mastro, L Bergaglio, M Lionetto, R Lunardi, G Sguotti, C Frevola, L Donati, S Rosso, R Cognetti, F
Citation: M. Venturini et al., Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients. (vol 12, pg 1097, 2001), ANN ONCOL, 12(10), 2001, pp. 1498-1498
Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: Resultsof a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group
Authors: Del Mastro, L Venturini, M Lionetto, R Carnino, F Guarneri, D Gallo, L Contu, A Pronzato, P Vesentini, L Bergaglio, M Comis, S Rosso, R
Citation: L. Del Mastro et al., Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: Resultsof a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group, J CL ONCOL, 19(8), 2001, pp. 2213-2221
Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients
Authors: Bertelli, G Queirolo, P Vecchio, S Angiolini, C Bergaglio, M Del Mastro, L Signorini, A Valenzano, M Venturini, M
Citation: G. Bertelli et al., Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients, ANTICANC R, 20(5C), 2000, pp. 3659-3661
Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients
Authors: Esposito, M Venturini, M Vannozzi, MO Tolino, G Lunardi, G Garrone, O Angiolini, C Viale, M Bergaglio, M Del Mastro, L Rosso, R
Citation: M. Esposito et al., Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients, J CL ONCOL, 17(4), 1999, pp. 1132-1140
Progestins and the endometrium in patients receiving tamoxifen
Authors: Bertelli, G Venturini, M Bergaglio, M Gustavino, C Rosso, R Valenzano, M
Citation: G. Bertelli et al., Progestins and the endometrium in patients receiving tamoxifen, BR J CANC, 80(7), 1999, pp. 1114-1114
Risultati: 1-7 |